162 related articles for article (PubMed ID: 4978514)
21. Clinical trials with a live attenuated rubella virus vaccine; Cendehill 51 strain.
Du Pan RM; Huggelen C; Peetermans J; Prinzie A
Am J Dis Child; 1968 Jun; 115(6):658-62. PubMed ID: 5690167
[No Abstract] [Full Text] [Related]
22. Intrauterine rubella infection following immunization with rubella vaccine.
Phillips CA; Maeck JV; Rogers WA; Savel H
JAMA; 1970 Jul; 213(4):624-5. PubMed ID: 4988108
[No Abstract] [Full Text] [Related]
23. [Cendehill strain of live and attenuated rubella virus vaccine. Development, production and tests].
Peetermans J; Huygelen C
Minerva Med; 1970 Apr; 61(30 Suppl):1560-9. PubMed ID: 4985793
[No Abstract] [Full Text] [Related]
24. Experimental live attenuated rubella virus vaccine. Clinical evaluation of Cendehill strain.
Prinzie A; Huygelen C; Gold J; Farquhar J; McKee J
Am J Dis Child; 1969 Aug; 118(2):172-7. PubMed ID: 5794812
[No Abstract] [Full Text] [Related]
25. Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.
Meyer HM; Parkman PD; Hobbins TE; Ennis FA
Am J Dis Child; 1968 Jun; 115(6):648-54. PubMed ID: 4968321
[No Abstract] [Full Text] [Related]
26. Present status of vaccines for rubella.
Sever JL
Arch Otolaryngol; 1973 Oct; 98(4):265-8. PubMed ID: 4205025
[No Abstract] [Full Text] [Related]
27. A trial with live attenuated rubella vaccine.
Lepow ML; Veronelli JA; Hostetler DD; Robbins FC
Am J Dis Child; 1968 Jun; 115(6):639-47. PubMed ID: 4968320
[No Abstract] [Full Text] [Related]
28. Immunization with live attenuated rubella virus vaccine (HPV-77). Clinical and serological results in children and adolescents in Israel.
Goldblum N; Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA
Am J Dis Child; 1969 Aug; 118(2):190-6. PubMed ID: 5815861
[No Abstract] [Full Text] [Related]
29. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.
Plotkin SA; Farquhar JD; Katz M; Buser F
Am J Dis Child; 1969 Aug; 118(2):178-85. PubMed ID: 5794813
[No Abstract] [Full Text] [Related]
30. Live, attenuated rubella-virus vaccine.
Hilleman MR; Buynak EB; Weibel RE; Stokes J
N Engl J Med; 1968 Aug; 279(6):300-3. PubMed ID: 4969117
[No Abstract] [Full Text] [Related]
31. Attenuation ob rubella virus by serial passage in primary rabbit kidney cell cultures. I. Growth characteristics in vitro and production of experimental vaccines at different passage levels.
Peetermans J; Huygelen C
Arch Gesamte Virusforsch; 1967; 21(2):133-43. PubMed ID: 4969301
[No Abstract] [Full Text] [Related]
32. Prospects for a rubella virus vaccine.
Parkman PD; Meyer HM
Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711
[No Abstract] [Full Text] [Related]
33. Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines.
Dudgeon JA; Marshall WC; Peckham CS
Am J Dis Child; 1969 Aug; 118(2):237-43. PubMed ID: 4893824
[No Abstract] [Full Text] [Related]
34. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
Grant L; Belle EA; Provan G; King SD; Sigel MM
J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
[TBL] [Abstract][Full Text] [Related]
35. Comparison of fluorescent antibody induced by rubella virus in vaccinee and convalescent individuals.
Serafini A; Cole GC; Brackett RG
Appl Microbiol; 1972 Jan; 23(1):66-71. PubMed ID: 4621798
[TBL] [Abstract][Full Text] [Related]
36. Stability of the rabbit immunogenic marker of RA 27-3 rubella vaccine virus after human passage.
Linnemann CC; Hutchinson L; Rotte TC; Hegg ME; Schiff GM
Infect Immun; 1974 Mar; 9(3):547-9. PubMed ID: 4206028
[TBL] [Abstract][Full Text] [Related]
37. The effects of Cendehill rubella vaccine in children under unusually complicated circumstances.
Chang TW; Dickinson PC; Weinstein L
J Infect Dis; 1969 Aug; 120(2):237-41. PubMed ID: 4980602
[No Abstract] [Full Text] [Related]
38. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing.
Buynak EB; Hilleman MR; Weibel RE; Stokes J
JAMA; 1968 Apr; 204(3):195-200. PubMed ID: 4172467
[No Abstract] [Full Text] [Related]
39. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus].
Fara GM; Galli MG; Nodari R; Saccani CF; Marangoni L; Bozzetti A; Tarantino F
Minerva Med; 1970 Apr; 61(30 Suppl):1574-7. PubMed ID: 5439721
[No Abstract] [Full Text] [Related]
40. Immunogenicity and reactogenicity of live attenuated rubella virus vaccines.
Andzhaparidze OG; Desyatskova RG; Chervonski GI; Pryanichnikova LV
Am J Epidemiol; 1970 May; 91(5):527-30. PubMed ID: 5462118
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
